Skip to Main Content

Paper Details

Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Proc Natl Acad Sci U S A
20
2020
Author NameAffiliation
Theodore P BraunKnight Cancer Institute, Oregon Health & Science University
Theodore P BraunOregon Health & Science University
Cody CoblentzKnight Cancer Institute, Oregon Health & Science University
Daniel J ColemanKnight Cancer Institute, Oregon Health & Science University
Zachary SchonrockKnight Cancer Institute, Oregon Health & Science University
Sarah A CarrattKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University
Julia E MaxsonOregon Health & Science University
  • 1 - 10

Datasets

Release 1.2